Internal Medicine, Rheumatology · Miami, FL
NPI
1174693345
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3661 S Miami Ave, 801
Miami, FL, 33133
Phone (305) 860-6260
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
1,761 services
Medicare patients, 2024
64
Average age 73
Drug cost, 2024
$4.2M
6,566 prescriptions
Company payments, 2025
$36.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul R Sweeney was code 99214 (office e&m - established), 56 times for 37 patients. In total Paul R Sweeney billed 1,761 services in 18 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 56 | 37 | $87.90 | $4,923 |
| 99213 Office E&M - Established | Office | 42 | 28 | $68.70 | $2,886 |
| 99204 Office E&M - New | Office | 20 | 20 | $134.73 | $2,695 |
By year: 2022 $60K for 2,233 services; 2023 $41K for 1,605 services; 2024 $45K for 1,761 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul R Sweeney prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,054 prescriptions and refills. In total Paul R Sweeney wrote 6,566 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,054 | 1,524 | 201 | $7,817 |
| Prednisone Generic | 582 | 686 | 187 | $2,263 |
| Leflunomide Generic | 545 | 866 | 124 | $35K |
| Hydroxychloroquine Sulfate Generic | 516 | 718 | 112 | $3,999 |
| Folic Acid Generic | 492 | 1,147 | 153 | $1,157 |
| Pregabalin Generic | 369 | 431 | 82 | $11K |
| Gabapentin Generic | 345 | 544 | 122 | $3,022 |
| Meloxicam Generic | 236 | 283 | 84 | $414 |
| Diclofenac Sodium Generic | 225 | 254 | 81 | $3,479 |
| Enbrel Sureclick Etanercept | 213 | 213 | 23 | $1.2M |
| Rinvoq Upadacitinib | 137 | 138 | 20 | $887K |
| Hadlima(Cf) Pushtouch Adalimumab-Bwwd | 131 | 133 | 14 | $94K |
| Alendronate Sodium Generic | 103 | 246 | 42 | $631 |
| Sulfasalazine Dr Sulfasalazine | 102 | 148 | 28 | $2,209 |
| Duloxetine Hcl Generic | 99 | 207 | 32 | $1,313 |
Brand drugs: 1,179 claims; generic drugs: 5,374 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul R Sweeney $36.4 ($36.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $36.4.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 2 | $36.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.